Literature DB >> 3040334

Interception. III: Postcoital luteal contragestion by an antiprogestin (mifepristone, RU 486) in 62 women.

M R van Santen, A A Haspels.   

Abstract

The new antiprogestin mifepristone (RU 486) was studied as an emergency postcoital contragestive. An actual pregnancy rate of 1.6% was observed and was related to the actual conception rate. The follow-up rate was 100%. The patterns of onset and duration of the induced menstruation after mifepristone treatment are described. This method provides a good new interceptive technique when the time for use of postcoital steroids or for a postcoital IUD insertion has lapsed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040334     DOI: 10.1016/0010-7824(87)90078-3

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  3 in total

Review 1.  Medical termination of pregnancy.

Authors:  J Guillebaud
Journal:  BMJ       Date:  1990 Aug 18-25

Review 2.  Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors:  R N Brogden; K L Goa; D Faulds
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

3.  Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception.

Authors:  A M Webb; J Russell; M Elstein
Journal:  BMJ       Date:  1992-10-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.